CRYOPORT, INC. Warrants Not Settleable in Cash, Fair Value Disclosure
CRYOPORT, INC. (CYRX) had Warrants Not Settleable in Cash, Fair Value Disclosure of $280.40 thousand as of 2015-03-31, per its 10-KT filed 2017-03-13.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:WarrantsNotSettleableInCashFairValueDisclosure · last filed 2017-03-13
- 2015-03-31: Warrants Not Settleable in Cash, Fair Value Disclosure $280.40K.
- 2013-08-12: Warrants Not Settleable in Cash, Fair Value Disclosure $92.17K.
- 2013-06-30: Warrants Not Settleable in Cash, Fair Value Disclosure $107.00K.
- 2012-06-30: Warrants Not Settleable in Cash, Fair Value Disclosure $0.00.
| Period end | Warrants Not Settleable in Cash, Fair Value Disclosure |
|---|---|
| 2015-03-31 | $280.40K 10-KT · filed 2017-03-13 |
| 2013-08-12 | $92.17K 10-Q · filed 2014-02-13 |
| 2013-06-30 | $107.00K 10-Q · filed 2013-08-14 |
| 2012-06-30 | $0.00 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |